Tadekinig alfa Uses, Dosage, Side Effects and more
Tadekinig alfa is under investigation in clinical trial NCT03113760 (Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiency).
| Attribute | Details |
|---|---|
| Trade Name | Tadekinig alfa |
| Generic | Tadekinig alfa |
| Tadekinig alfa Other Names | Tadekinig alfa |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
